IMM-BCP-01
IMM-BCP-1001
Phase 1 small_molecule terminated
Quick answer
IMM-BCP-01 for SARS-CoV2 Infection is a Phase 1 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- SARS-CoV2 Infection
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated